RU2013146757A - METHOD FOR MODELING NSAID-HEPATOPATHY IN EXPERIMENT - Google Patents
METHOD FOR MODELING NSAID-HEPATOPATHY IN EXPERIMENT Download PDFInfo
- Publication number
- RU2013146757A RU2013146757A RU2013146757/14A RU2013146757A RU2013146757A RU 2013146757 A RU2013146757 A RU 2013146757A RU 2013146757/14 A RU2013146757/14 A RU 2013146757/14A RU 2013146757 A RU2013146757 A RU 2013146757A RU 2013146757 A RU2013146757 A RU 2013146757A
- Authority
- RU
- Russia
- Prior art keywords
- hepatopathy
- nsaid
- experiment
- modeling
- steroidal anti
- Prior art date
Links
- 208000019423 liver disease Diseases 0.000 title claims abstract 3
- 239000000041 non-steroidal anti-inflammatory agent Substances 0.000 claims abstract 6
- 229940021182 non-steroidal anti-inflammatory drug Drugs 0.000 claims abstract 6
- 241001465754 Metazoa Species 0.000 claims abstract 2
- 241000700159 Rattus Species 0.000 claims abstract 2
- 230000037396 body weight Effects 0.000 claims abstract 2
Landscapes
- Investigating Or Analysing Biological Materials (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Abstract
Способ моделирования НПВП-гепатопатии в эксперименте путем перорального введения лабораторным крысам нестероидного противовоспалительного препарата, отличающийся тем, что в качестве нестероидного противовоспалительного препарата используют Найз® в разовой дозе 5 мг/кг массы тела животного, один раз в день, курсом 21 день. A method for simulating NSAID hepatopathy in an experiment by oral administration of a non-steroidal anti-inflammatory drug to laboratory rats, characterized in that Nize® is used as a non-steroidal anti-inflammatory drug in a single dose of 5 mg / kg of animal body weight, once a day, for 21 days.
Claims (1)
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| RU2013146757/14A RU2013146757A (en) | 2013-10-18 | 2013-10-18 | METHOD FOR MODELING NSAID-HEPATOPATHY IN EXPERIMENT |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| RU2013146757/14A RU2013146757A (en) | 2013-10-18 | 2013-10-18 | METHOD FOR MODELING NSAID-HEPATOPATHY IN EXPERIMENT |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| RU2013146757A true RU2013146757A (en) | 2015-04-27 |
Family
ID=53282978
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| RU2013146757/14A RU2013146757A (en) | 2013-10-18 | 2013-10-18 | METHOD FOR MODELING NSAID-HEPATOPATHY IN EXPERIMENT |
Country Status (1)
| Country | Link |
|---|---|
| RU (1) | RU2013146757A (en) |
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| RU2610536C1 (en) * | 2015-10-20 | 2017-02-13 | Федеральное государственное бюджетное научное учреждение "Научно-исследовательский институт акушерства, гинекологии и репродуктологии имени Д.О. Отта" | Method for simulating acute liver disease in pregnant women |
-
2013
- 2013-10-18 RU RU2013146757/14A patent/RU2013146757A/en unknown
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| RU2610536C1 (en) * | 2015-10-20 | 2017-02-13 | Федеральное государственное бюджетное научное учреждение "Научно-исследовательский институт акушерства, гинекологии и репродуктологии имени Д.О. Отта" | Method for simulating acute liver disease in pregnant women |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| MX392839B (en) | SELF-REGULATED RELEASE OF ACTIVE PHARMACEUTICAL INGREDIENT. | |
| EA201690223A1 (en) | FACTOR INHIBITORS IN THE COMPLEMENT BASED ON PIPERIDININILINDOL DERIVATIVES AND THEIR APPLICATION | |
| EA201390184A1 (en) | ACTIVATING AMRK HETEROCYCLIC COMPOUNDS AND METHODS FOR THEIR USE | |
| CL2016001111A1 (en) | Formulations of azaindole compounds. | |
| EA201490228A1 (en) | NEW DERIVATIVES OF TRIFTOROMETHYLOROXIAZOLE AND THEIR APPLICATION FOR THE TREATMENT OF DISEASE | |
| EA201491060A1 (en) | NEW DERIVATIVES OF TRIFTOROMETHYLOROXIAZOLE AND THEIR APPLICATION FOR THE TREATMENT OF DISEASE | |
| EA201791293A1 (en) | SITE SPECIFIC DOSING OF BTK INHIBITOR | |
| EA201592256A1 (en) | DERIVATIVES OF IMIDAZOPIRROLIDINONE AND THEIR APPLICATION IN THE TREATMENT OF DISEASES | |
| EA201690246A1 (en) | AUTOTOXIN INHIBITORS CONTAINING A NUCLEAR HETEROAROMATIC RING-BENZYL-AMIDE CYCLE | |
| EA201201658A1 (en) | DERIVATIVES OF PIPERIDINE AND THEIR APPLICATION FOR THE TREATMENT OF METABOLIC DISORDERS | |
| BR112016029750A2 (en) | intermittent dosage of mdm2 inhibitor | |
| PH12015500823A1 (en) | Modified release formulations for oprozomib | |
| EA201591259A1 (en) | SOLID FORMS OF HINAZOLIN DERIVATIVE AND THEIR APPLICATION AS A BRAF INHIBITOR | |
| EA201691299A1 (en) | APPLICATION OF LACHINIMODA TO SLOW DOWN THE PROGRESSION OF HANTINGTON'S DISEASE | |
| PH12015502717B1 (en) | Anti-fibrogenic compounds, methods and uses thereof | |
| CL2016000397A1 (en) | Cancer treatment | |
| RU2013146757A (en) | METHOD FOR MODELING NSAID-HEPATOPATHY IN EXPERIMENT | |
| UY34080A (en) | PHARMACEUTICAL COMPOSITION FOR ORAL ADMINISTRATION THAT INCLUDES FEXOFENADINE AND PREPARATION METHODS | |
| RU2012121242A (en) | METHOD OF PHARMACOLOGICAL CORRECTION OF ISCHEMIA OF THE SKELETAL MUSCLE BY NICORANDIL | |
| RU2012112099A (en) | METHOD OF PHARMACOLOGICAL CORRECTION OF SKELETAL ISCHEMIA ISCHEMIA MINOXIDIL | |
| EA201301232A1 (en) | DOSAGE FORM FOR TARGETING OF ACTIVE SUBSTANCES | |
| RU2012112098A (en) | METHOD FOR INCREASING SURGERY OF THE SKIN FLAP IN THE CONDITIONS OF REDUCED BLOOD CIRCULATION BY MINOXIDYL | |
| RU2012152490A (en) | METHOD FOR PHARMACOLOGICAL CORRECTION OF ISCHEMIA OF THE SKELETAL MUSCLE WITH RESVERATROLOM | |
| RU2012121971A (en) | METHOD FOR MODELING THE STATE OF INDUCTION OF FUNCTIONAL ACTIVITY OF GLYCOPROTEIN-R FINASTERIDE IN EXPERIMENT | |
| RU2011134925A (en) | METHOD FOR INCREASING RADIOSENSIBILIZATION OF ANIMAL TISSUES |